NCT01751945

Brief Summary

The purpose of this study is to determine whether an integrated EmONC package (community mobilization, training of community-based health care providers and a maternal and neonatal health pack) reduce perinatal and neonatal mortality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12,000

participants targeted

Target at P75+ for not_applicable sepsis

Timeline
Completed

Started Nov 2012

Shorter than P25 for not_applicable sepsis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2012

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

November 16, 2012

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 18, 2012

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

June 9, 2016

Status Verified

June 1, 2016

Enrollment Period

1.1 years

First QC Date

November 16, 2012

Last Update Submit

June 8, 2016

Conditions

Keywords

EmONCNeonatal mortalityPerinatal mortality

Outcome Measures

Primary Outcomes (1)

  • Perinatal mortality

    12 months

Study Arms (2)

EmONC package

EXPERIMENTAL

The EmONC package consists of: 1. Maternal and neonatal health pack(clean delivery kit, emollient, chlorhexidine, sms messages) for safe motherhood and newborn wellbeing. 2. Enhanced trainings of community-level health care providers to provide effective maternal and neonatal health services and referral of complicated cases to health facilities and creation of linkages amongst health care providers. 3. Community mobilisation

Behavioral: EmONC package

Standard of care

NO INTERVENTION

Standard care as per national policy

Interventions

EmONC packageBEHAVIORAL

The EmONC package consists of: 1. Maternal and neonatal health pack(clean delivery kit, emollient, chlorhexidine, sms messages) for safe motherhood and newborn wellbeing. 2. Enhanced trainings of community-level health care providers to provide effective maternal and neonatal health services and referral of complicated cases to health facilities and creation of linkages amongst health care providers. 3. Community mobilisation

EmONC package

Eligibility Criteria

Age15 Years - 49 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Expectant women and their newborns in the study area

You may not qualify if:

  • Pregnant women not belonging to the study area

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Field Site

Rahim Yar Khan, Punjab Province, Pakistan

Location

Related Publications (2)

  • Ariff S, Jiwani U, Rizvi A, Muhammad S, Hussain A, Ahmed I, Hussain M, Usman M, Iqbal J, Memon Z, Soofi SB, Bhutta ZA. Effect of Maternal and Newborn Care Service Package on Perinatal and Newborn Mortality: A Cluster Randomized Clinical Trial. JAMA Netw Open. 2024 Feb 5;7(2):e2356609. doi: 10.1001/jamanetworkopen.2023.56609.

  • Turab A, Ariff S, Habib MA, Ahmed I, Hussain M, Rashid A, Memon Z, Khan MI, Soofi S, Bhutta ZA. Improved accessibility of emergency obstetrics and newborn care (EmONC) services for maternal and newborn health: a community based project. BMC Pregnancy Childbirth. 2013 Jun 24;13:136. doi: 10.1186/1471-2393-13-136.

MeSH Terms

Conditions

SepsisPneumoniaAsphyxia NeonatorumRespiratory Distress SyndromeEclampsiaPostpartum HemorrhagePuerperal InfectionPerinatal Death

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsRespiratory Tract InfectionsLung DiseasesRespiratory Tract DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesRespiration DisordersHypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesObstetric Labor ComplicationsPuerperal DisordersUterine HemorrhageHemorrhagePregnancy Complications, InfectiousDeath

Study Officials

  • Dr. Sajid Soofi, MBBS, FCPS

    Aga Khan University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 16, 2012

First Posted

December 18, 2012

Study Start

November 1, 2012

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

June 9, 2016

Record last verified: 2016-06

Data Sharing

IPD Sharing
Will share

Locations